Olanzapine and clozapine use in a woman with schizophrenia during consecutive pregnancies: a case report

dc.authorscopusid56088124400
dc.contributor.authorKöse Çınar R.
dc.date.accessioned2024-06-12T10:24:58Z
dc.date.available2024-06-12T10:24:58Z
dc.date.issued2016
dc.description.abstractData on the safety of antipsychotic use during pregnancy remain inconclusive. Here, we report the history of a woman with schizophrenia who had two pregnancies while receiving prolactin-sparing antipyschotic drugs. The case supports existing data showing that the use of olanzapine and clozapine (on separate occasions) during pregnancy results in uncomplicated deliveries of healthy infants. © 2016, Springer International Publishing Switzerland.en_US
dc.identifier.doi10.1007/s40267-016-0328-z
dc.identifier.endpage405en_US
dc.identifier.issn1172-0360
dc.identifier.issue9en_US
dc.identifier.scopus2-s2.0-84983432398en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage403en_US
dc.identifier.urihttps://doi.org/10.1007/s40267-016-0328-z
dc.identifier.urihttps://hdl.handle.net/20.500.14551/16124
dc.identifier.volume32en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherSpringer International Publishingen_US
dc.relation.ispartofDrugs and Therapy Perspectivesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectClozapine; Olanzapine; Risperidone; Adult; Article; Auditory Hallucination; Bipolar Disorder; Case Report; Cesarean Section; Delusion; Disease Exacerbation; Drug Dose Increase; Drug Substitution; Drug Withdrawal; Female; Hebephrenia; Hospital Admission; Human; Hyperprolactinemia; Mania; Negative Syndrome; Optimal Drug Dose; Paranoia; Schizophrenia; Treatment Duration; Treatment Refusal; Unplanned Pregnancy; Young Adulten_US
dc.titleOlanzapine and clozapine use in a woman with schizophrenia during consecutive pregnancies: a case reporten_US
dc.typeArticleen_US

Dosyalar